Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency.
about
Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data.Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose.Safety of ferric carboxymaltose immediately after infliximab administration, in a single session, in inflammatory bowel disease patients with iron deficiency: a pilot study.Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations.A fast-track anaemia clinic in the Emergency Department: feasibility and efficacy of intravenous iron administration for treating sub-acute iron deficiency anaemiaCurrent management of iron deficiency anemia in inflammatory bowel diseases: a practical guide.Ferric carboxymaltose: a review of its use in iron deficiency.Advances in Pediatric Intravenous Iron Therapy.Pre-operative haematological assessment in patients scheduled for major surgery.A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000.A fast-track anaemia clinic in the Emergency Department: cost-analysis of intravenous iron administration for treating iron-deficiency anaemia.Current misconceptions in diagnosis and management of iron deficiencyA controlled study of the effects of ferric carboxymaltose on bone and haematinic biomarkers in chronic kidney disease and pregnancy.Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.Intravenous iron treatments for iron deficiency anemia in inflammatory bowel disease: a budget impact analysis of iron isomaltoside 1000 (Monofer) in the UK.Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice.Ferric carboxymaltose reduces the number of red blood cell units transfused and allows transfusion independence to be obtained in patients with iron deficiency anemia secondary to gastrointestinal chronic blood loss.Increased Plasmodium chabaudi malaria mortality in mice with nutritional iron deficiency can be reduced by short-term adjunctive iron supplementation.The safety of available treatment options for iron-deficiency anemia.Modern iron replacement therapy: clinical and pathophysiological insights.Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients.Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean womenRole of intravenous iron in the treatment of anemia in patients with gastrointestinal tract tumors undergoing chemotherapy: a single-center, observational study
P2860
Q30670881-35B81CCB-3869-4350-9E09-6A9E1103C339Q34700903-772D9188-12DF-48E1-A05F-A05123B629C3Q35642045-775E6E0A-290B-4071-A052-6A9A8083449BQ35898038-EDCE9418-F424-4D23-AC3A-BF46002E01E4Q36660755-60D2B96D-1EF7-4897-8E44-EB273929FB25Q38151564-7083C420-EF0C-4FA0-8DE5-F64CE0AE446EQ38271890-10F91E87-E160-417B-959B-3CB78A3FD4A5Q38587940-6E0108DE-FB69-469D-AA79-AFFFE600DB98Q38653566-4016FBAC-7619-445C-8106-2C6162FE89FAQ41405604-A60316FB-9728-4261-8E02-E3C5B43765E6Q41547007-C762DED9-9274-426D-A203-3D17125E43C8Q41547046-6CD73A55-2450-491E-B59A-E5B2DF4D2B00Q47428974-70B3E983-DE05-4461-A695-84F825F5EF7CQ47734653-16AFFE83-B960-43CF-AF27-1E9C0769BFBDQ47793365-FFC0D5F8-E268-466B-94B8-AA4AFEEBC452Q47821861-8F059977-A836-40B0-BE36-D8C3830EC60BQ48008043-45892EB2-2A4A-4988-AB83-3FE575E873C9Q48022231-92748FB5-CB39-4187-9ED1-502CE1D41B85Q48548255-1E363C21-B22D-4AE0-97B4-9F4AB46C239CQ49351942-7FCE9DDD-A1A6-4657-9968-726E076DEA42Q53730269-A9C67273-B267-44FA-8FB7-13F7D58444E8Q57213576-AE629863-C5FC-4A0C-86A1-414B5EDA273EQ58719897-3A77BDC1-F8C6-4D75-BDA3-A23D105B88D2
P2860
Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cost-minimization analysis fav ...... ent of severe iron deficiency.
@ast
Cost-minimization analysis fav ...... ent of severe iron deficiency.
@en
Cost-minimization analysis fav ...... ent of severe iron deficiency.
@nl
type
label
Cost-minimization analysis fav ...... ent of severe iron deficiency.
@ast
Cost-minimization analysis fav ...... ent of severe iron deficiency.
@en
Cost-minimization analysis fav ...... ent of severe iron deficiency.
@nl
prefLabel
Cost-minimization analysis fav ...... ent of severe iron deficiency.
@ast
Cost-minimization analysis fav ...... ent of severe iron deficiency.
@en
Cost-minimization analysis fav ...... ent of severe iron deficiency.
@nl
P2093
P2860
P1433
P1476
Cost-minimization analysis fav ...... ment of severe iron deficiency
@en
P2093
Albert Villoria
Angelina Dosal
Ariadna Figuerola
David Suarez
Emili Gené
Laura Moreno
Maria López
Miquel Àngel Ruíz
Mireia Miquel
P2860
P304
P356
10.1371/JOURNAL.PONE.0045604
P407
P577
2012-09-21T00:00:00Z